Elevated uric acid correlates with wound severity

International Wound Journal

Volumn 9, Issue 2, 2012, Pages 139-149

  Fernandez, Melissa L ^a   Upton, Zee ^a   Edwards, Helen ^a   Finlayson, Kathleen ^a   Shooter, Gary K ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Chronic venous leg ulcers; Purines; Uric acid; Wound fluid and xanthine oxidase

Indexed keywords

ADENOSINE; FREE RADICAL; HYPOXANTHINE; INOSINE; PURINE; URIC ACID; XANTHINE OXIDASE;

ADULT; AGED; ARTICLE; CATALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; HYPERURICEMIA; INFLAMMATION; LEG ULCER; MALE; PRIORITY JOURNAL; WOUND; WOUND FLUID;

AGED; BLOTTING, WESTERN; CHRONIC DISEASE; EXUDATES AND TRANSUDATES; HUMANS; LEG ULCER; MALE; MIDDLE AGED; ULTRAFILTRATION; URIC ACID; XANTHINE OXIDASE;

EID: 84858281907     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2011.00870.x     Document Type: Article

References (50)

1. Baker SR, Stacey MC. Epidemiology of chronic leg ulcers in Australia. Aust N Z J Surg 1994;64: 258-61.
2. Briggs M, Close SJ. The prevalence of leg ulceration: a review of the literature. EWMA J 2003;3:14-20.
3. Margolis DJ, Bilker W, Santanna J, Baumgarten M. Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 2002;46:381-6.
4. Simon DA, Dix FP, McCollum CN. Management of venous leg ulcers. BMJ 2004;328:1358-62.
5. Lorimer KR, Harrison MB, Graham ID, Friedberg E, Davies B. Assessing venous ulcer population characteristics and practices in a home care community. Ostomy Wound Manage 2003;49:32-4, 8-40, 2-3.
6. Abbade LP, Lastoria S, de Almeida Rollo H, Stolf HO. A sociodemographic, clinical study ofpatients with venous ulcer. Int J Dermatol 2005; 44:989-92.
7. Walker N, Rodgers A, Birchall N, Norton R, MacMahon S. Leg ulcers in New Zealand: age at onset, recurrence and provision of care in an urban population. N Z Med J 2002;115:286-9.
8. Edwards H, Courtney M, Finlayson K, Lindsay E, Lewis C, Shuter P, Chang A. Chronic venous leg ulcers: effect of a community nursing intervention on pain and healing. Nurs Stand 2005;19: 47-54.
9. Walshe C. Living with a venous leg ulcer: a descriptive study of patients' experiences. J Adv Nurs 1995;22:1092-100.
10. Chase S, Whittemore R, Crosby N, Freney D. Living with chronic venous ulcers: A descriptive study of knowledge and functional health status. J Commun Health Nurs 2000;17:1-13.
11. Kurd SK, Hoffstad OJ, Bilker WB, Margolis DJ. Evaluation of the use of prognostic information for the care of individuals with venous leg ulcers or diabetic neuropathic foot ulcers. Wound Repair Regen 2009;17:318-25.
12. van der Vliet A, Bove PF. Purinergic signaling in wound healing and airway remodeling. Subcell Biochem 55:139-57.
13. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312: 159-63.
14. Kuracka L, Kalnovicova T, Liska B, Turcani P. HPLC method for measurement of purine nucleotide degradation products in cerebrospinal fluid. Clin Chem 1996;42:756-60.
15. Stover JF, Lowitzsch K, Kempski OS. Cerebrospinal fluid hypoxanthine, xanthine and uric acid levels may reflect glutamate-mediated excitotoxicity in different neurological diseases. Neurosci Lett 1997;238:25-8.
16. Gizzi F, Papponetti M, Palka GD, Ruffini I, Di Ilio C, Odorisio M, Spoto G. Hypoxanthine and xanthine as markers in early diagnosis of foetal diseases. Adv Exp Med Biol 1998;431:777-80.
17. Amorini AM, Petzold A, Tavazzi B, Eikelenboom J, Keir G, Belli A, Giovannoni G, Di Pietro V, Polman C, D'Urso S, Vagnozzi R, Uitdehaag B, Lazzarino G. Increase of uric acid and purine compounds in biological fluids of multiple sclerosis patients. Clin Biochem 2009;42:1001-6.
18. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 2002;33:774-97.
19. Pritsos CA. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact 2000;129: 195-208.
20. Vorbach C, Harrison R, Capecchi MR. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol 2003;24:512-7.
21. Darr D, Fridovich I. Free radicals in cutaneous biology. J Invest Dermatol 1994;102:671-5.
22. Finaud J, Lac G, Filaire E. Oxidative stress: relationship with exercise and training. Sports Med 2006; 36:327-58.
23. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem 2005;12: 1161-208.
24. Wlaschek M, Scharffetter-Kochanek K. Oxidative stress in chronic venous leg ulcers. Wound Repair Regen 2005;13:452-61.
25. Stotts NA, Rodeheaver GT, Thomas DR, Frantz RA, Bartolucci AA, Sussman C, Ferrell BA, Cuddigan J, Maklebust J. An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH). J Gerontol A Biol Sci Med Sci 2001;56:M795-9.
26. Fernandez ML, Broadbent JA, Shooter GK, Malda J, Upton Z. Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid. Br J Dermatol 2008;158:281-90.
27. Hoke SH, Morand KL, Greis KD, Baker TR, Harbol KL, Dobson RLM. Transformations in pharmaceutical research and development, driven by innovations in multidimensional mass spectrometry-based technologies. Int J Mass Spectr 2001;212:135-96 [DOI: 10.1016/S1387-3806(01)00499-7].
28. Hon J, Lagden K, McLaren A-M, O'sullivan D, Orr L, Houghton PE, Woodbury MG. A prospective, multicentre study to validate use of the pressure ulcer scale of healing [PUSH] in patients with diabetic, venous, and pressure ulcers. Ostomy Wound Manage 2010;56:26-36.
29. Sarnesto A, Linder N, Raivio KO. Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. Lab Invest 1996;74:48-56.
30. Parker RB, McCollam PL. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia. Clin Pharm 1990;9:261-71.
31. Hayashida M, Fukunaga A, Fukuda K, Sakurai S, Mamiya H, Ichinohe T, Kaneko Y, Hanaoka K. The characteristics of intravenous adenosine-induced antinociception in a rabbit model of acute nociceptive pain: a comparative study with remifentanil. Anesth Analg 2006;103:1004-10.
32. Granger DN, Hollwarth ME, Parks DA. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand Suppl 1986;548: 47-63.
33. Montesinos MC, Gadangi P, Longaker M, Sung J, Levine J, Nilsen D, Reibman J, Li M, Jiang CK, Hirschhorn R, Recht PA, Ostad E, Levin RI, Cronstein BN. Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors. J Exp Med 1997;186:1615-20.
34. Montesinos MC, Desai A, Chen JF, Yee H, Schwarzschild MA, Fink JS, Cronstein BN. Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol 2002;160:2009-18.
35. Jiang S, Zavitz CC, Wang J, Saraf A, Zielinski R, Ramsbottom JD, Ballerini P, D'Alimonte I, Romano S, Fischione G, Traversa U, Werstiuk ES, Rathbone MP. Non-adenine based purines accelerate wound healing. Purinergic Signal 2006;2:651-61.
36. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 2005;67:1385-7.
37. Valls MD, Cronstein BN, Montesinos MC. Adenosine receptor agonists for promotion of dermal wound healing. Biochem Pharmacol 2009;77: 1117-24.
38. Kono H, Chen CJ, Ontiveros F, Rock KL. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010;120: 1939-49.
39. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med 1961;54:452-60.
40. Shi Y, Mucsi AD, Ng G. Monosodium urate crystals in inflammation and immunity. Immunol Rev 2010;233:203-17.
41. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology 2003;189:41-54.
42. Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol 1991;1:39-42.
43. Meyer M, Schreck R, Baeuerle PA. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. Embo J 1993;12:2005-15.
44. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition 1996;12:274-7.
45. Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med 1996;21: 335-48.
46. Halliwell B, Gutteridge J. Free radicals in biology and medicine, 3rd edn. New York: Oxford University Press Inc, 1999.
47. Wenk J, Brenneisen P, Wlaschek M, Poswig A, Briviba K, Oberley TD, Scharffetter-Kochanek K. Stable overexpression of manganese superoxide dismutase in mitochondria identifies hydrogen peroxide as a major oxidant in the AP-1-mediated induction of matrix-degrading metalloprotease-1. J Biol Chem 1999;274:25869-76.
48. Yeoh-Ellerton S, Stacey MC. Iron and 8-isoprostane levels in acute and chronic wounds. J Invest Dermatol 2003;121:918-25.
49. Moseley R, Hilton JR, Waddington RJ, Harding KG, Stephens P, Thomas DW. Comparison of oxidative stress biomarker profiles between acute and chronic wound environments. Wound Repair Regen 2004;12:419-29.
50. Moran LK, Gutteridge JM, Quinlan GJ. Thiols in cellular redox signalling and control. Curr Med Chem 2001;8:763-72.